Rayvio_News_Filter
$SER 🏥
Serina Therapeutics initiated dosing in Cohort 2 of the registrational study of SER-252 in Parkinson's disease after an independent safety monitoring committee recommended advancement.
Curated for market relevance
2

About SER
Neutral Sentiment
How do you feel about SER?